MeSH D009202 - cardiomyopathies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D009202:
Cardiomyopathies
0 Companies
0 Drugs
Success rate
D002310:Alcoholic cardiomyopathy
0 Companies
0 Drugs
Success rate
D002311:Dilated cardiomyopathy
D002313:Restrictive cardiomyopathy
0 Companies
0 Drugs
Success rate
D002598:Chagas cardiomyopathy
0 Companies
0 Drugs
Success rate
D004695:Endocardial fibroelastosis
0 Companies
0 Drugs
Success rate
D004719:Endomyocardial fibrosis
0 Companies
0 Drugs
Success rate
D007625:Kearns-sayre syndrome
0 Companies
0 Drugs
Success rate
D009205:Myocarditis
0 Companies
0 Drugs
Success rate
D015428:Myocardial reperfusion injury
0 Companies
0 Drugs
Success rate
D019571:Arrhythmogenic right ventricular dysplasia
0 Companies
0 Drugs
Success rate
D052120:Glycogen storage disease type iib
0 Companies
0 Drugs
Success rate
D058065:Diabetic cardiomyopathies
0 Companies
0 Drugs
Success rate
D058088:Sarcoglycanopathies
0 Companies
0 Drugs
Success rate
D054549:Takotsubo cardiomyopathy
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
75%6/8
Phase 2
50%7/14
Phase 3
14%2/14
Approved: 0Overall Success rate: 5%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use